Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month to end a short-lived partnership to sell its Wegovy weight-loss drug ...

Hims & Hers Health Inc. board members and executives failed to tell shareholders that its Novo Nordisk A/S Wegovy ...

Hims & Hers bounced back by 8.64 percent on Monday to close at $52.03 following announcements that it remains open to working ...

What's more, as the U.S. IPO market heats back up, more of these deals could follow, said Angelo Bochanis, an analyst at Renaissance Capital, a provider of pre-IPO research and IPO-focused ETFs.

Wall Street’s main indices finished in the green but with lackluster gains, with the Nasdaq rising 0.27 percent, the S&P 500 ...

NVO shares fall 19.9% year to date amid weak CagriSema data, CEO exit and rising pressure from rivals in obesity care.

The First Trust Mid Cap Growth AlphaDEX ETF (FNY) made its debut on 04/19/2011, and is a smart beta exchange traded fund that ...

Lawsuits against airlines are not uncommon, but recent allegations by workers are beyond belief. Two former United Airlines ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...

Joyce Ong'ombe was unwell owing to a boiler accident in the house where she was living in with her daughter in Diani. Her nephew Calvin helped her.

BHUBANESWAR: The Higher Education department on Monday directed all the universities and colleges in the state to submit ...

In July 2025, the U.S. markets have been experiencing mixed movements as inflation data and earnings reports from major financial institutions influence investor sentiment. Despite these fluctuations, ...